Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Fry, John S ^a   Hamling, Jan S ^a   Lee, Peter N ^a  

^a PN Lee Statistics and Computing Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; COHORT ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HUMAN; LUNG CANCER; LUNG FUNCTION; MALE; META ANALYSIS; PREDICTION; PUBLICATION; RISK FACTOR; RISK REDUCTION; SMOKING; SYSTEMATIC REVIEW;

EID: 84867772912     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-498     Document Type: Article

References (46)

1. Calabrò E, Randi G, La Vecchia C, Sverzellati N, Marchianò A, Villani M, Zompatori M, Cassandro R, Harari S, Pastorino U. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J 2010, 35:146-151. 10.1183/09031936.00049909, 19679603.
2. Eberly LE, Ockene J, Sherwin R, Yang L, Kuller L. Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters. Int J Epidemiol 2003, 32:592-599. 10.1093/ije/dyg177, 12913035.
3. Hole DJ, Watt GCM, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996, 313:711-715. 10.1136/bmj.313.7059.711, 2352103, 8819439.
4. Islam SS, Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol Biomarkers Prev 1994, 3:289-298.
5. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis 1990, 141:613-617. 10.1164/ajrccm/141.3.613, 2310094.
6. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58:388-393. 10.1136/thorax.58.5.388, 1746680, 12728157.
7. Nomura A, Stemmermann GN, Chyou P-H, Marcus EB, Buist AS. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 1991, 144:307-311. 10.1164/ajrccm/144.2.307, 1859052.
8. Peto R. The Oxford overview of cholesterol-lowering trials: cause-specific mortality rates. Low Blood Cholesterol: Health Implications 1993, 29-30. London: Current Medical Literature, Lewis B, Paoletti R, Tikkanen MJ.
9. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study. Ann Intern Med 1986, 105:503-507.
10. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987, 106:512-518.
11. Wasswa-Kintu S, Gan WQ, Man SFP, Dare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005, 60:570-575. 10.1136/thx.2004.037135, 1747470, 15994265.
12. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2010, Ottawa Health Research Institute, http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp?status=print.
13. Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 1993, 4:218-228. 10.1097/00001648-199305000-00005, 8512986.
14. Fry JS, Lee PN. Revisiting the association between environmental tobacco smoke exposure and lung cancer risk. I. The dose-response relationship with amount and duration of smoking by the husband. Indoor + Built Environment 2000, 9:303-316.
15. Gardner MJ, Altman DG. Statistics with confidence. Confidence intervals and statistical guidelines 1989, London: British Medical Journal.
16. Hamling J, Lee P, Weitkunat R, Ambühl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008, 27:954-970. 10.1002/sim.3013, 17676579.
17. US Department of Health and Human Services National health and nutrition examination survey (NHANES) National Center for Health Statistics, http://www.cdc.gov/nchs/nhanes.htm], US Department of Health and Human Services.
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159:179-187.
19. Carta P, Cocco PL, Casula D. Mortality from lung cancer among Sardinian patients with silicosis. Br J Ind Med 1991, 48:122-129. 1035332, 1998606.
20. Speizer FE, Fay ME, Dockery DW, Ferris BG. Chronic obstructive pulmonary disease mortality in six US cities. Am J Respir Crit Care Med 1989, 140:S49-S55.
21. Stavem K, Aaser E, Sandvik L, Bjornholt JV, Erikssen G, Thaulow E, Erikssen J. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005, 25:618-625. 10.1183/09031936.05.00008504, 15802334.
22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634. 10.1136/bmj.315.7109.629, 2127453, 9310563.
23. Beaty TH, Newill CA, Cohen BH, Tockman MS, Bryant SH, Spurgeon HA. Effects of pulmonary function on mortality. J Chronic Dis 1985, 38:703-710. 10.1016/0021-9681(85)90024-4, 4019706.
24. Chau N, Benamghar L, Pham QT, Teculescu D, Rebstock E, Mur JM. Mortality of iron miners in Lorraine (France): relations between lung function and respiratory symptoms and subsequent mortality. Br J Ind Med 1993, 50:1017-1031. 1035537, 8280627.
25. Chien JW, Au DH, Barnett MJ, Goodman GE. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers. COPD 2007, 4:339-346. 10.1080/15412550701601340, 18027161.
26. Cullen MR, Barnett MJ, Balmes JR, Cartmel B, Redlich CA, Brodkin CA, Barnhart S, Rosenstock L, Goodman GE, Hammar SP, et al. Predictors of lung cancer among asbestos-exposed men in the β-carotene and retinol efficacy trial. Am J Epidemiol 2005, 161:260-270. 10.1093/aje/kwi034, 15671258.
27. Finkelstein MM. Clinical measures, smoking, radon exposure, and risk of lung cancer in uranium miners. Occup Environ Med 1996, 53:697-702. 10.1136/oem.53.10.697, 1128577, 8943835.
28. Hanlon P, Walsh D, Whyte BW, Scott SN, Lightbody P, Gilhooly MLM. The link between major risk factors and important categories of admission in an ageing cohort. J Public Health Med 2011, 22:81-89.
29. Harber P, Oren A, Mohsenifar Z, Lew M. Obstructive airway disease as a risk factor for asbestos-associated malignancy. J Occup Med 1986, 28:82-86.
30. Kuller LH, Ockene JK, Meilahn E, Svendsen K. Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Epidemiol 1990, 132:265-274.
31. Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer?: a nested case-control study using quantitative emphysema analysis. Chest 2010, 138:1295-1302. 10.1378/chest.09-2567, 20348193.
32. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States. Data from the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003, 163:1475-1480. 10.1001/archinte.163.12.1475, 12824098.
33. Menotti A, Conti S, Giampaoli S, Mariotti S, Signoretti P. Coronary risk factors predicting coronary and other causes of death in fifteen years. Acta Cardiol 1980, 35:107-120.
34. Menotti A, Mariotti S, Seccareccia S, Giampaoli S. The 25 year estimated probability of death from some specific causes as a function of twelve risk factors in middle aged men. Eur J Epidemiol 1988, 4:60-67. 10.1007/BF00152694, 3356235.
35. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM, Higgins ITT, Gray RG, Richards SM, Gilliland J, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983, 128:491-500.
36. Pham QT, Gaertner M, Mur JM, Braun P, Gabiano M, Sadoul P. Incidence of lung cancer among iron miners. Eur J Respir Dis 1983, 64:534-540.
37. Purdue MP, Gold L, Järvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007, 62:51-56. 10.1136/thx.2006.064196, 2111275, 16928722.
38. Schottenfeld D. COPD increases risk of lung cancer in smokers [Medigram]. Am Fam Physician 1992, 45:2728.
39. Tammemagi MC, Lam SC, McWilliams AM, Sin DD. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res 2011, 4:552-561.
40. van den Eeden SK, Friedman GD. Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology 1992, 3:253-257. 10.1097/00001648-199205000-00011, 1591325.
41. Vestbo J, Rasmussen FV. The single breath nitrogen test, mortality, and cancer. Am Rev Respir Dis 1990, 142:1022-1025.
42. Vestbo J, Knudsen KM, Rasmussen V. Are respiratory symptoms and chronic airflow limitation really associated with an increased risk of respiratory cancer?. Int J Epidemiol 1991, 20:375-378. 10.1093/ije/20.2.375, 1917237.
43. Wiles FJ, Hnizdo E. Relevance of airflow obstruction and mucus hypersecretion to mortality. Respir Med 1991, 85:27-35.
44. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM, Shapiro SD, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008, 178:738-744. 10.1164/rccm.200803-435OC, 2556456, 18565949.
45. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012, 175:66-73. 10.1093/aje/kwr265, 3244608, 22135359.
46. Fletcher C, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema. An eight-year study of early chronic obstructive lung disease in working men in London. Oxford 1976, New York, Toronto: Oxford University Press.